Apollo Medical - AMEH Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $47.20
  • Forecasted Upside: 15.63%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$40.82
▼ -0.88 (-2.11%)
Get New Apollo Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMEH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMEH

Analyst Price Target is $47.20
▲ +15.63% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Apollo Medical in the last 3 months. The average price target is $47.20, with a high forecast of $55.00 and a low forecast of $41.00. The average price target represents a 15.63% upside from the last price of $40.82.

This chart shows the closing price for AMEH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 polled investment analysts is to moderate buy stock in Apollo Medical. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/30/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/30/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/29/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/27/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/25/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/24/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/26/2024Jefferies Financial GroupInitiated CoverageBuy$50.00Low
2/22/2024Bank of AmericaUpgradeNeutral ➝ Buy$44.00 ➝ $55.00Low
1/24/2024Stifel NicolausInitiated CoverageBuy$45.00Low
12/22/2023Truist FinancialInitiated CoverageHold$41.00Low
10/17/2023BTIG ResearchInitiated CoverageBuy$45.00Low
4/12/2023Bank of AmericaInitiated CoverageNeutral$44.00Low
2/27/2023Lake Street CapitalBoost TargetBuy$40.00 ➝ $60.00Low
12/19/2022Lake Street CapitalInitiated CoverageBuy$40.00Low
9/21/2022William BlairInitiated CoverageOutperformLow
8/8/2022BarclaysBoost TargetEqual Weight$50.00 ➝ $57.00Low
3/22/2022Colliers SecuritiesReiterated RatingBuyLow
8/12/2021BarclaysInitiated CoverageEqual Weight$92.00High
8/10/2021Colliers SecuritiesReiterated RatingBuyHigh
6/25/2021Colliers SecuritiesBoost TargetTop Pick ➝ Buy$36.00 ➝ $75.00High
(Data available from 7/23/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2023
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/25/2024
  • 7 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/24/2024
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/24/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/24/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/23/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Apollo Medical logo
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.
Read More

Today's Range

Now: $40.82
Low: $40.71
High: $42.75

50 Day Range

MA: $39.79
Low: $35.30
High: $41.70

52 Week Range

Now: $40.82
Low: $28.86
High: $43.12

Volume

313,900 shs

Average Volume

166,711 shs

Market Capitalization

$2.38 billion

P/E Ratio

40.82

Dividend Yield

N/A

Beta

1.04

Frequently Asked Questions

What sell-side analysts currently cover shares of Apollo Medical?

The following sell-side analysts have issued reports on Apollo Medical in the last year: Bank of America Co., BTIG Research, Jefferies Financial Group Inc., Stifel Nicolaus, and Truist Financial Co..
View the latest analyst ratings for AMEH.

What is the current price target for Apollo Medical?

5 Wall Street analysts have set twelve-month price targets for Apollo Medical in the last year. Their average twelve-month price target is $47.20, suggesting a possible upside of 15.6%. Bank of America Co. has the highest price target set, predicting AMEH will reach $55.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $41.00 for Apollo Medical in the next year.
View the latest price targets for AMEH.

What is the current consensus analyst rating for Apollo Medical?

Apollo Medical currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AMEH.

What other companies compete with Apollo Medical?

How do I contact Apollo Medical's investor relations team?

Apollo Medical's physical mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company's listed phone number is (626) 282-0288 and its investor relations email address is [email protected]. The official website for Apollo Medical is www.apollomed.net. Learn More about contacing Apollo Medical investor relations.